GILEAD SCIENCES INC (1GILD.MI) Stock Price, Forecast & Analysis
Europe • Euronext Milan • BIT:1GILD • US3755581036
1GILD.MI Key Statistics, Chart & Performance
The current stock price of 1GILD.MI is 117.06 EUR. In the past month the price increased by 11.59%.
1GILD.MI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to 1GILD.MI.
1GILD.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI. While 1GILD.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
1GILD.MI Financial Highlights
Over the last trailing twelve months 1GILD.MI reported a non-GAAP Earnings per Share(EPS) of 6.84. The EPS increased by 84.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.88% | ||
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| Debt/Equity | 0 |
1GILD.MI Forecast & Estimates
37 analysts have analysed 1GILD.MI and the average price target is 110.22 EUR. This implies a price decrease of -5.85% is expected in the next year compared to the current price of 117.06.
For the next year, analysts expect an EPS growth of 80.6% and a revenue growth 3.16% for 1GILD.MI
1GILD.MI Ownership
About 1GILD.MI
Company Profile
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,600 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. The company is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. The company also develops the HB-400 program and the HB-500 program. The company develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. The company has a cancer program, namely TREX1. The company operates in more than 35 countries worldwide.
Company Info
GILEAD SCIENCES INC
333 Lakeside Dr
Foster City CALIFORNIA US
Employees: 17600
Phone: 16505743000
GILEAD SCIENCES INC / 1GILD.MI FAQ
What does GILEAD SCIENCES INC do?
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,600 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. The company is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. The company also develops the HB-400 program and the HB-500 program. The company develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. The company has a cancer program, namely TREX1. The company operates in more than 35 countries worldwide.
What is the current price of 1GILD stock?
The current stock price of 1GILD.MI is 117.06 EUR. The price increased by 4.11% in the last trading session.
What is the dividend status of GILEAD SCIENCES INC?
GILEAD SCIENCES INC (1GILD.MI) has a dividend yield of 2.51%. The yearly dividend amount is currently 2.67.
What is the ChartMill rating of GILEAD SCIENCES INC stock?
1GILD.MI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the sector and industry classification for GILEAD SCIENCES INC?
GILEAD SCIENCES INC (1GILD.MI) operates in the Health Care sector and the Biotechnology industry.
What is the employee count for 1GILD stock?
GILEAD SCIENCES INC (1GILD.MI) currently has 17600 employees.
What is GILEAD SCIENCES INC worth?
GILEAD SCIENCES INC (1GILD.MI) has a market capitalization of 145.23B EUR. This makes 1GILD.MI a Large Cap stock.